Among the three recently described GB viruses (GBV-A, GBV-B, and GBV-C), only GBV-C has been linked to cryptogenic hepatitis in man. Because of the limited utility of currently available research tests to determine antibody response t o GBV-C proteins, the prevalence of GBV-C RNA in human sera was s
Community prevalence of hepatitis C viraemia: A polymerase chain reaction study
✍ Scribed by Richard Sallie; Ruth King; Eduardo Silva; Christopher Tibbs; Phillip Johnson; Roger Williams
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 470 KB
- Volume
- 43
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
In order to estimate the prevalence of HCV carriage in an inner city health district, we undertook a polymerase chain reaction (PCR) based survey of sera collected from 1,002 patients attending general practitioners for reasons unrelated to liver disease. The series comprised 305 sample selected sera patients sample from sera 995 patients previously screened by C100 antigen‐based anti‐HCV tests. Overall, 7 patients were positive for HCV RNA. Four cases had anti‐C100 antibodies to HCV, 2 were strictly negative but had high‐normal/borderline optical densities by ELISA assay, while one was completely anti‐HCV negative. All but one had normal liver function tests. Only 3/7 PCR positive cases had any serum marker for hepatitis B (HBV) exposure (2 HBsAg positive, 1 IgM anti‐HBc positive). The minimum point prevalence of HCV carriage in this community is 0.7%, approximating the HBsAg carriage in the same population (1%). HCV carriage in this inner city population is considerably higher than would be predicted by blood donor surveys. A positive anti‐HCV antibody (anti‐C100) test is poorly predictive (∼10%) of HCV RNA carriage in a general practice based population in which measurement of “surrogate” (HBV related) HCV markers would have detected only 3/7 cases of presumed chronic HCV carriage. © 1994 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
Eq/mL, P õ .01). There was no difference in the pre-Hepatitis C virus (HCV) replicates at a low rate, treatment proportion of HCV RNA -positive hepatoand this makes its detection and intrahepatic localcytes among patients with different biochemical reization difficult. To evaluate the clinical impli
## Abstract The mean prevalence of anti‐hepatitis C virus (HCV) in Italy is 0.87%. It reaches 2% in Campania, Southern Italy. Approximately 50% of community acquired non‐A, non‐B (NANB) hepatitis cannot be associated with known parenteral exposure. A recent Italian study has shown that the only dem
In a population-based survey, 39 (0.90%) of 4,496 Saudi Arabian children (ages 1 to 10) were positive for antibody to hepatitis C virus. No significant difference was seen between the prevalence rate in males (0.9%) and females (0.8%) or between urban (0.7%) and rural dwellers (1.0%). A significant